Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbalip.2011.07.009PMID 21801852
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enzymological studies on the biosynthesis of N-acylethanolamines.

  2010cited by this paper
• Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo.

  2010cited by this paper
• Effect of synthetic and natural phospholipids on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D activity.

  2009cited by this paper
• Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis

  2009cited by this paper
• Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain

  2008cited by this paper
• Anandamide Biosynthesis Catalyzed by the Phosphodiesterase GDE1 and Detection of Glycerophospho-N-acyl Ethanolamine Precursors in Mouse Brain*

  2008cited by this paper
• Multiple pathways involved in the biosynthesis of anandamide.

  2008cited by this paper
• Biosynthetic Pathways of the Endocannabinoid Anandamide

  2007cited by this paper
• Endocannabinoid Biosynthesis Proceeding through Glycerophospho-N-acyl Ethanolamine and a Role for α/β-Hydrolase 4 in This Pathway*

  2006cited by this paper
• Functional Analysis of the Purified Anandamide-generating Phospholipase D as a Member of the Metallo-β-lactamase Family*

  2006cited by this paper
• A biosynthetic pathway for anandamide

  2006cited by this paper
• Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids.

  2006cited by this paper
• The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

  2005cited by this paper
• The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide

  2005cited by this paper
• Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners*

  2004cited by this paper
• Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D.

  2004cited by this paper
• Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.

  2004cited by this paper
• Modulation of anxiety through blockade of anandamide hydrolysis

  2003cited by this paper
• The palmitoylethanolamide family: a new class of anti-inflammatory agents?

  2002cited by this paper
• Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations.

  2001cited by this paper
• An anorexic lipid mediator regulated by feeding

  2001cited by this paper
• N-Acylethanolamines and precursor phospholipids - relation to cell injury.

  2000cited by this paper
• Widespread recombinase expression using FLPeR (Flipper) mice

  2000cited by this paper
• Electrospray ionization mass spectrometric method for the determination of cannabinoid precursors: N-acylethanolamine phospholipids (NAPEs).

  1999cited by this paper
• Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.

  1996cited by this paper
• Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta.

  1994cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• N-acylated glycerophospholipids and their derivatives.

  1990cited by this paper
• Purification and Properties of Phospholipase D from Actinomadura sp. Strain No. 362

  1987cited by this paper
• Catabolism of N‐Acylethanolamine Phospholipids by Dog Brain Preparations

  1984cited by this paper
• Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type.

  1983cited by this paper
• Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium.

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Acyl and alk-1-enyl group compositions of the alk-1'-enyl acyl and the diacyl glycerophosphoryl ethanolamines of mouse and ox brain.

  1969cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper

• Cannabidiol–Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma

  2026cites this paper
• Genetic deletion of NAPE-PLD alters stress responsiveness and HPA-axis functionality in a context-dependent manner in mice.

  2025cites this paper
• The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets.

  2025cites this paper
• Integrating endocannabinoid signaling, CCK interneurons, and hippocampal circuit dynamics in behaving animals

  2025cites this paper
• The endocannabinoid and paracannabinoid systems in natural reward processes: possible pharmacological targets?

  2025cites this paper
• Characterization of cell-type specific knockout of different elements of the endocannabinoid system in cortical glutamatergic neurons in the context of stress-induced behavioral phenotype

  2025cites this paper
• Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation

  2025cites this paper
• PLAAT5 as an N-acyltransferase responsible for the generation of anti-inflammatory N-acylethanolamines in testis.

  2024cites this paper
• Genetic deletion of NAPE-PLD induces context-dependent dysregulation of anxiety-like behaviors, stress responsiveness, and HPA-axis functionality in mice

  2024cites this paper
• Genetic Tools in Rodents to Study Cannabinoid Functions.

  2024cites this paper
• Higher Plasma Levels of Endocannabinoids and Analogues Correlate With a Worse Cardiometabolic Profile in Young Adults

  2023cites this paper
• The genetics of gaits in Icelandic horses goes beyond DMRT3, with RELN and STAU2 identified as two new candidate genes

  2023cites this paper
• Fluorescence-Based NAPE-PLD Activity Assay.

  2023cites this paper
• Regulation of plasmalogen biosynthesis in mammalian cells and tissues.

  2023cites this paper
• Nicotine exposure during breastfeeding alters the expression of endocannabinoid system biomarkers in female but not in male offspring at adulthood

  2023cites this paper
• Determination and Comparison of Soybean Lecithin and Bovine Brain Plasmalogens Effects in Healthy Male Wistar Rats

  2023cites this paper
• NAPE-PLD deletion in stress-TRAPed neurons results in an anxiogenic phenotype

  2023cites this paper
• Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

  2023cites this paper
• PLAAT1 deficiency alleviates high‐fat diet‐induced hepatic lipid accumulation in mice

  2023cites this paper
• Corylus avellana “Nocciola Piemonte”: metabolomics focused on polar lipids and phenolic compounds in fresh and roasted hazelnuts

  2023cites this paper
• Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS

  2023cites this paper
• (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders

  2022cites this paper
• Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities.

  2022cites this paper
• Formation of N-acyl-phosphatidylethanolamines by cytosolic phospholipase A2ε in an ex vivo murine model of brain ischemia.

  2022cites this paper
• Group IVE cytosolic phospholipase A2 limits psoriatic inflammation by mobilizing the anti‐inflammatory lipid N‐acylethanolamine

  2022cites this paper
• Involvement of the γ Isoform of cPLA2 in the Biosynthesis of Bioactive N-Acylethanolamines

  2021cites this paper
• Selective measurement of NAPE-PLD activity via a PLA1/2-resistant fluorogenic N-acyl-phosphatidylethanolamine analog

  2021cites this paper
• Roles of Endocannabinoids and Endocannabinoid-like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective.

  2021cites this paper
• Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox

  2021cites this paper
• NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes.

  2021cites this paper
• Involvement of acid ceramidase in the degradation of bioactive N-acylethanolamines.

  2021cites this paper
• Plasmalogens, platelet-activating factor and beyond – Ether lipids in signaling and neurodegeneration

  2020influential citation
• Plasma endocannabinoids and cannabimimetic fatty acid derivatives are altered in gastroparesis: A sex‐ and subtype‐dependent observation

  2020cites this paper
• Druggable Lipid Signaling Pathways

  2020cites this paper
• The cannabinoid agonist WIN-2 affects acquisition but not consolidation of a spatial information in training and retraining processes: relation with transcriptional regulation of the endocannabinoid system?

  2020cites this paper
• Druggable Targets in Endocannabinoid Signaling.

  2020cites this paper
• Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism

  2020cites this paper
• Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice

  2020cites this paper
• The Basal Pharmacology of Palmitoylethanolamide

  2020cites this paper
• Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS/MS[S]

  2019cites this paper
• Lipid-metabolizing serine hydrolases in the mammalian central nervous system: endocannabinoids and beyond.

  2019cites this paper
• Covalent Modification of Phosphatidylethanolamine by Benzyl Isothiocyanate and the Resultant Generation of Ethanolamine Adduct as Its Metabolite.

  2019cites this paper
• Intracellular Ca2+-dependent formation of N-acyl-phosphatidylethanolamines by human cytosolic phospholipase A2ε.

  2019cites this paper
• Physiology of the Endocannabinoid System During Development.

  2019cites this paper
• The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review

  2019cites this paper
• Phosphatidylserine-stimulated production of N-acyl-phosphatidylethanolamines by Ca2+-dependent N-acyltransferase.

  2018cites this paper
• The Biosynthetic Pathways of N‐Acylethanolamines in Mammals

  2018cites this paper
• Lysophosphatidic acid in medicinal herbs enhances prostaglandin E2 and protects against indomethacin-induced gastric cell damage in vivo and in vitro.

  2018cites this paper
• Multi-class polar lipid profiling in fresh and roasted hazelnut (Corylus avellana cultivar "Tonda di Giffoni") by LC-ESI/LTQOrbitrap/MS/MSn.

  2018cites this paper
• Endocannabinoids and related N-acylethanolamines: biological activities and metabolism

  2018cites this paper
• Dietary fatty acids augment tissue levels of n-acylethanolamines in n-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) knockout mice.

  2018cites this paper
• NAPE‐PLD controls OEA synthesis and fat absorption by regulating lipoprotein synthesis in an in vitro model of intestinal epithelial cells

  2018cites this paper
• Basic Mechanisms of Synthesis and Hydrolysis of Major Endocannabinoids

  2017cites this paper
• Pharmacological Aspects of Anandamide and 2-Arachidonoyglycerol as Bioactive Lipids

  2017cites this paper
• Peripheral tissue levels and molecular species compositions of N-acyl-phosphatidylethanolamine and its metabolites in mice lacking N-acyl-phosphatidylethanolamine-specific phospholipase D

  2017cites this paper
• Oleoylethanolamide: A fat ally in the fight against obesity.

  2017cites this paper
• Roles of N-Acylethanolamines in Brain Functions and Neuropsychiatric Diseases

  2017cites this paper
• NAPE Phospholipase D Enzyme and Recent Advances in the Understanding of its Biological Properties

  2017cites this paper
• Oleic acid-derived oleoylethanolamide: A nutritional science perspective.

  2017cites this paper
• An involvement of phospholipase A/acyltransferase family proteins in peroxisome regulation and plasmalogen metabolism

  2017cites this paper
• Endocannabinoid Turnover.

  2017cites this paper
• Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and Repair

  2017cites this paper
• Mammalian enzymes responsible for the biosynthesis of N-acylethanolamines.

  2017influential citation
• Inflammation of peripheral tissues and injury to peripheral nerves induce differing effects in the expression of the calcium‐sensitive N‐arachydonoylethanolamine‐synthesizing enzyme and related molecules in rat primary sensory neurons

  2017cites this paper
• A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)

  2016cites this paper
• Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions

  2016cites this paper
• Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases

  2016cites this paper
• Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.

  2016cites this paper
• Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives

  2016cites this paper
• Quantitative analysis of N‐acylphosphatidylethanolamine molecular species in rat brain using solid‐phase extraction combined with reversed‐phase chromatography and tandem mass spectrometry

  2016cites this paper
• Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review).

  2016cites this paper
• Calcium-dependent generation of N-acylethanolamines and lysophosphatidic acids by glycerophosphodiesterase GDE7.

  2016cites this paper
• Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure

  2016cites this paper
• Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition

  2016cites this paper
• An Introduction to the Endogenous Cannabinoid System.

  2016cites this paper
• The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI‐101 prevents cisplatin‐induced nephrotoxicity

  2016cites this paper
• Lipids and Oxidative Stress Associated with Ethanol-Induced Neurological Damage

  2016cites this paper
• Assay of NAPE-PLD Activity.

  2016cites this paper
• Cannabinoid-dopamine interactions: Modulation of midbrain DA neurons by endocannabinoids

  2015cites this paper
• Glycerophosphodiesterase GDE4 as a novel lysophospholipase D: a possible involvement in bioactive N-acylethanolamine biosynthesis.

  2015cites this paper
• Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling

  2015cites this paper
• Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals?

  2015cites this paper
• Metabolic Enzymes for Endocannabinoids and Endocannabinoid-Like Mediators

  2015cites this paper
• Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota

  2015cites this paper
• Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies

  2015cites this paper
• The Endocannabinoid Signaling System in the CNS: A Primer.

  2015cites this paper
• Genetic Manipulation of the Endocannabinoid System.

  2015cites this paper
• Non-endocannabinoid N-Acylethanolamines and Monoacylglycerols: Old Molecules New Targets

  2015cites this paper
• ABHD4 regulates multiple classes of N-acyl phospholipids in the mammalian central nervous system.

  2015cites this paper
• Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives.

  2014cites this paper
• New players in the fatty acyl ethanolamide metabolism.

  2014cites this paper
• Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat.

  2014cites this paper
• Endocannabinoids, Related Compounds and Their Metabolic Routes

  2014cites this paper
• Endocannabinoid biochemistry: What do we know after 50 years?

  2014cites this paper
• Classical endocannabinoid‐like compounds and their regulation by nutrients

  2014cites this paper
• Harnessing the anti-inflammatory potential of palmitoylethanolamide.

  2014cites this paper
• Genetic dissection of the endocannabinoid system and how it changed our knowledge of cannabinoid pharmacology and mammalian physiology

  2014cites this paper
• Occurrence and Implications of the N-Acylethanolamine Metabolic Pathway in Physcomitrella patens

  2014cites this paper
• The emerging physiological roles of the glycerophosphodiesterase family

  2014cites this paper
• Phospholipid profiles of control and glaucomatous human aqueous humor.

  2014cites this paper